Tag: BENIGN PROSTATIC HYPERPLASIA
SIR and Congressional Men’s Health Caucus collaborate on PAE briefing
On 5 June, the Society of Interventional Radiology (SIR) held a briefing in Washington DC, USA, of which the focus was benign prostate hyperplasia...
Registry reinforces safety, efficacy and efficiency of radial access in visceral...
The final results of the RAVI prospective registry study demonstrated the safety and efficacy of radial access in visceral interventions in standard embolization procedures...
Rivermark Medical announces successful first-in-human use of its FloStent System for...
Rivermark Medical has announced the successful first-in-human (FIH) use of its FloStent System as part of the company's RAPID-1 FIH clinical study. The procedures...
Teleflex announces collaboration with FundamentalVR to improve training through virtual reality...
Teleflex has announced a new agreement with FundamentalVR, a company providing virtual reality (VR) integration for medical simulation. The agreement will provide Teleflex with...
Teleflex granted reimbursement approval for the “UroLift System” in Japan
Teleflex Incorporated have announced that the company has received reimbursement approval from the Central Social Insurance Medical Council of Japan (Chuikyo) for the UroLift...
Real-time imaging: Ultrasound detects a biodegradable embolic microsphere after prostatic artery...
Researchers report the use of ultrasound to detect embolization in real time for patients undergoing treatment for benign prostatic hyperplasia (BPH). Richard Owen (University...
Evidence propels prostate artery embolization into becoming a “standard of care”...
The support of the UK’s National Institute for Health and Care Excellence (NICE) signals that embolization has a unique role in the treatment of benign prostatic...
